Form 4: Tenaya CMO Sells Shares for Tax Obligations

Tenaya Therapeutics' Chief Medical Officer, Tingley Whittemore, sold 2,877 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Chief Medical Officer Tingley Whittemore of Tenaya Therapeutics, Inc. sold 2,877 shares of common stock.
• The transaction occurred on November 17, 2025, at a price of $1.33 per share.
• The sale was specifically to cover tax withholding obligations associated with the vesting of restricted stock units awarded on January 24, 2025.
• Following this transaction, the reporting person beneficially owns 169,926 shares, which includes 85,838 shares from unvested restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a routine 'sell to cover' for tax withholding purposes related to vested restricted stock units, which is a common and non-discretionary event for executives. It does not indicate a change in management's confidence or company fundamentals.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This filing reports a routine insider transaction related to executive compensation, specifically a 'sell to cover' for tax obligations upon RSU vesting. This is a common practice across industries for executives receiving equity-based compensation and does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• The impact on shareholders is minimal as this is a small, non-discretionary sale by an executive for tax purposes, not indicative of a change in company outlook or management confidence.

Key Dates

Keywords

Tenaya Therapeutics, TNYA, Form 4, Insider Transaction, Stock Sale, Chief Medical Officer, Restricted Stock Units, Tax Withholding, Beneficial Ownership